The U.S. Food and Drug Administration has lifted a clinical hold on three cell therapies being developed by CARsgen ...

Vijayawada: The Andhra Sugars Limited has undergone US FDA inspection at their aspirin manufacturing facility at ...

Novo Nordisk A/S was cited for quality lapses at a drug production plant in Denmark that makes the hit medicines Ozempic and ...

The investigation focuses on Humacyte’s statements about the FDA’s inspections and the company ... 2024 sent her a letter on Form 483 which was not published until October 17, 2024 that ...

Pharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food ...

There is no shortage of ASX healthcare companies with upcoming catalysts – a focal point for investors. ... Read More The ...

From April 8-12, the U.S. FDA had conducted a comprehensive pre-approval inspection (PAI) and cGMP audit, which concluded with zero Form 483 observations, Granules said. “The successful completion of ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Hyderabad: Granules India Limited, a pharmaceutical manufacturing company, has announced that it has received an ...

Targets the reduction in CABG-related bleeding severity due to the blood thinning drug, ticagrelor – a major unmet medical need in heart attack ...

Hagens Berman urges investors in Humacyte, Inc. (NASDAQ: HUMA) who suffered substantial losses to submit your losses now .